Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) (Ascending) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
51138-0155-42 51138-0155 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0155-50 51138-0155 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-10 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-12 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-14 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-15 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-20 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-21 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51138-0156-30 51138-0156 Prednisone Prednisone Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 18, 2011 March 26, 2012 No Longer Used
51144-0001-60 51144-0001 Tucatinib TUKYSA 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor HER2 Oral April 17, 2020 In Use
51144-0002-12 51144-0002 Tucatinib TUKYSA 150.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor HER2 Oral April 17, 2020 In Use
51144-0002-60 51144-0002 Tucatinib TUKYSA 150.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor HER2 Oral April 17, 2020 In Use
51144-0003-01 51144-0003 Tisotumab vedotin TIVDAK 40.0 mg/4mL Immunotherapy Drug Antibody Conjugate Tissue factor Intravenous Sept. 20, 2021 In Use
51144-0020-01 51144-0020 ENFORTUMAB VEDOTIN PADCEV 20.0 mg/2mL Immunotherapy Drug Antibody Conjugate Nectin-4 Intravenous Dec. 18, 2019 In Use
51144-0030-01 51144-0030 ENFORTUMAB VEDOTIN PADCEV 30.0 mg/3mL Immunotherapy Drug Antibody Conjugate Nectin-4 Intravenous Dec. 18, 2019 In Use
51144-0050-01 51144-0050 Brentuximab vedotin Adcetris 50.0 mg/10.5mL Immunotherapy Drug Antibody Conjugate CD30 Intravenous Aug. 25, 2011 In Use
51285-0366-01 51285-0366 Methotrexate Trexall 5.0 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral May 3, 2001 In Use
51285-0367-01 51285-0367 Methotrexate Trexall 7.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral May 3, 2001 In Use
51285-0368-01 51285-0368 Methotrexate Trexall 10.0 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral May 3, 2001 In Use
51285-0369-01 51285-0369 Methotrexate Trexall 15.0 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral May 3, 2001 In Use
51407-0181-12 51407-0181 Abiraterone Acetate Abiraterone Acetate 250.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor CYP17 Inhibitor Oral Jan. 16, 2019 In Use
51407-0748-02 51407-0748 Cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous March 20, 2023 In Use
51407-0749-05 51407-0749 Cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous March 20, 2023 In Use
51407-0750-10 51407-0750 Cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous March 20, 2023 In Use
51407-0760-12 51407-0760 Sorafenib Sorafenib 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FLT, PDGFR, KIT, RET, RET/PTC, CRAF, BRAF Oral April 14, 2023 In Use

Found 10,000 results in 13 milliseconds — Export these results